No CrossRef data available.
Article contents
Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022
Published online by Cambridge University Press: 24 March 2025
Abstract
In the United States, New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacterales (CRE) are frequently associated with healthcare encounters. From September 2021 to September 2022, 21 patients with NDM-CRE identified from urine and without healthcare exposure were reported to the Centers for Disease Control and Prevention. Isolates were genetically similar to healthcare-associated strains.
- Type
- Concise Communication
- Information
- Creative Commons
- To the extent this is a work of the US Government, it is not subject to copyright protection within the United States. To the extent this work is subject to copyright outside the United States, the US Government retains a paid-up, non exclusive irrevocable, worldwide licence to reproduce, prepare derivative works, distribute copies to the public and display publicly the Contribution, and to permit others to do so. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
- Copyright
- © The Society for Healthcare Epidemiology of America, 2025
References
Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf, 2019.Google Scholar
Bulens, SN, et al., Carbapenem-resistant Enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015. Am J Infect Control 2023;51(1):70–77.CrossRefGoogle ScholarPubMed
Janelle, SJ, et al., Notes from the field: New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacteriaceae identified in patients without known health care Risk Factors - Colorado, 2014-2016. MMWR Morb Mortal Wkly Rep 2016; 65(49):1414–1415.CrossRefGoogle Scholar
Wirth, T, et al., Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006;60(5):1136–1151.CrossRefGoogle ScholarPubMed
Zhou, Z, et al., The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res 2020;30(1): 138–152.CrossRefGoogle ScholarPubMed
Voor In ‘t Holt, AF, et al., Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors. Antimicrob Resist Infect Control 2020;9(1):71.CrossRefGoogle Scholar
Erdem, I, et al., Community-acquired lower urinary tract infections: etiology, antimicrobial resistance, and treatment results in female patients. J Glob Infect Dis 2018;10(3):129–132.CrossRefGoogle ScholarPubMed
Gronthal, T, et al., Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015. Euro Surveill 2018;23(27):1700497.CrossRefGoogle Scholar
Ramirez-Castillo, FY, Guerrero-Barrera, AL, and Avelar-Gonzalez, FJ, An overview of carbapenem-resistant organisms from food-producing animals, seafood, aquaculture, companion animals, and wildlife. Front Vet Sci 2023;10:1158588.CrossRefGoogle ScholarPubMed
Sader, HS, et al., Changing epidemiology of carbapenemases among carbapenem-resistant Enterobacterales from United States hospitals and the activity of Aztreonam-Avibactam against contemporary Enterobacterales (2019-2021). Open Forum Infect Dis 2023; 10(2):ofad046.CrossRefGoogle ScholarPubMed